var data={"name":"Plasma cell disorders","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Monoclonal gammopathy","type":"SUBSECTION","items":[{"name":"Clinical course and management of monoclonal gammopathy of undetermined significance","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-course-and-management-of-monoclonal-gammopathy-of-undetermined-significance"},{"name":"Diagnosis of monoclonal gammopathy of undetermined significance","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-of-monoclonal-gammopathy-of-undetermined-significance"},{"name":"Laboratory methods for analyzing monoclonal proteins","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=laboratory-methods-for-analyzing-monoclonal-proteins"}]},{"name":"Multiple myeloma","type":"SUBSECTION","items":[{"name":"Allogeneic hematopoietic cell transplantation in multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=allogeneic-hematopoietic-cell-transplantation-in-multiple-myeloma"},{"name":"Autologous hematopoietic cell transplantation in multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=autologous-hematopoietic-cell-transplantation-in-multiple-myeloma"},{"name":"Clinical features, evaluation, and diagnosis of kidney disease in multiple myeloma and other monoclonal gammopathies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-evaluation-and-diagnosis-of-kidney-disease-in-multiple-myeloma-and-other-monoclonal-gammopathies"},{"name":"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-laboratory-manifestations-and-diagnosis-of-multiple-myeloma"},{"name":"Diagnosis and management of solitary extramedullary plasmacytoma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-management-of-solitary-extramedullary-plasmacytoma"},{"name":"Diagnosis and management of solitary plasmacytoma of bone","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-management-of-solitary-plasmacytoma-of-bone"},{"name":"Epidemiology, pathogenesis, and etiology of kidney disease in multiple myeloma and other monoclonal gammopathies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-pathogenesis-and-etiology-of-kidney-disease-in-multiple-myeloma-and-other-monoclonal-gammopathies"},{"name":"Evaluating response to treatment of multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluating-response-to-treatment-of-multiple-myeloma"},{"name":"Evaluation and management of complete and impending pathologic fractures in patients with metastatic bone disease, multiple myeloma, and lymphoma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-and-management-of-complete-and-impending-pathologic-fractures-in-patients-with-metastatic-bone-disease-multiple-myeloma-and-lymphoma"},{"name":"Laboratory methods for analyzing monoclonal proteins","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=laboratory-methods-for-analyzing-monoclonal-proteins"},{"name":"Management of multiple myeloma in resource-poor settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-multiple-myeloma-in-resource-poor-settings"},{"name":"Overview of the management of multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-management-of-multiple-myeloma"},{"name":"Pathobiology of multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathobiology-of-multiple-myeloma"},{"name":"Plasma cell leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=plasma-cell-leukemia"},{"name":"Selection of initial chemotherapy for symptomatic multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selection-of-initial-chemotherapy-for-symptomatic-multiple-myeloma"},{"name":"Smoldering multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=smoldering-multiple-myeloma"},{"name":"Staging and prognostic studies in multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=staging-and-prognostic-studies-in-multiple-myeloma"},{"name":"The use of osteoclast inhibitors in patients with multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-use-of-osteoclast-inhibitors-in-patients-with-multiple-myeloma"},{"name":"Treatment and prognosis of kidney disease in multiple myeloma and other monoclonal gammopathies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-kidney-disease-in-multiple-myeloma-and-other-monoclonal-gammopathies"},{"name":"Treatment of relapsed or refractory multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-relapsed-or-refractory-multiple-myeloma"},{"name":"Treatment of the complications of multiple myeloma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-the-complications-of-multiple-myeloma"}]},{"name":"Other","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-the-mixed-cryoglobulinemia-syndrome-essential-mixed-cryoglobulinemia"},{"name":"POEMS syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=poems-syndrome"},{"name":"The heavy chain diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-heavy-chain-diseases"},{"name":"Treatment of the mixed cryoglobulinemia syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-the-mixed-cryoglobulinemia-syndrome"}]},{"name":"Primary amyloidosis","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of amyloid cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-amyloid-cardiomyopathy"},{"name":"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-laboratory-manifestations-and-diagnosis-of-immunoglobulin-light-chain-al-amyloidosis"},{"name":"Gastrointestinal amyloidosis: Clinical manifestations, diagnosis, and management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=gastrointestinal-amyloidosis-clinical-manifestations-diagnosis-and-management"},{"name":"Overview of amyloidosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-amyloidosis"},{"name":"Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-immunoglobulin-light-chain-al-amyloidosis-and-light-and-heavy-chain-deposition-diseases"},{"name":"Renal amyloidosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=renal-amyloidosis"},{"name":"Treatment and prognosis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-immunoglobulin-light-chain-al-amyloidosis-and-light-and-heavy-chain-deposition-diseases"},{"name":"Treatment of amyloid cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-amyloid-cardiomyopathy"}]},{"name":"Waldenstrom macroglobulinemia","type":"SUBSECTION","items":[{"name":"Epidemiology, pathogenesis, clinical manifestations, and diagnosis of Waldenström macroglobulinemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-pathogenesis-clinical-manifestations-and-diagnosis-of-waldenstrom-macroglobulinemia"},{"name":"Treatment and prognosis of Waldenström macroglobulinemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-waldenstrom-macroglobulinemia"}]}]}